Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan to Prevent LV Remodeling in Pacemaker Patients
NCT01805804Phase 4Terminated
- Sponsor
- Medical University of Silesia
- Start
- Jan 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valsartan in Left ventricular remodeling (LVR), sponsored by Medical University of Silesia. Started Jan 2017; status: terminated.
02
Drugs
valsartan
03
Conditions
Left ventricular remodeling (LVR)
Beyond the preview
Go deeper on NCT01805804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01805804.